1: Gupta A, Singh AK, Kumar R, Ganguly R, Rana HK, Pandey PK, Sethi G, Bishayee A, Pandey AK. Corilagin in Cancer: A Critical Evaluation of Anticancer Activities and Molecular Mechanisms. Molecules. 2019 Sep 19;24(18):3399. doi: 10.3390/molecules24183399. PMID: 31546767; PMCID: PMC6767293.
2: Wu C, Huang H, Choi HY, Ma Y, Zhou T, Peng Y, Pang K, Shu G, Yang X. Anti- esophageal Cancer Effect of Corilagin Extracted from Phmllanthi Fructus via the Mitochondrial and Endoplasmic Reticulum Stress Pathways. J Ethnopharmacol. 2021 Apr 6;269:113700. doi: 10.1016/j.jep.2020.113700. Epub 2020 Dec 17. PMID: 33346026.
3: Xu J, Zhang G, Tong Y, Yuan J, Li Y, Song G. Corilagin induces apoptosis, autophagy and ROS generation in gastric cancer cells in vitro. Int J Mol Med. 2019 Feb;43(2):967-979. doi: 10.3892/ijmm.2018.4031. Epub 2018 Dec 18. PMID: 30569134; PMCID: PMC6317684.
4: Tong Y, Zhang G, Li Y, Xu J, Yuan J, Zhang B, Hu T, Song G. Corilagin inhibits breast cancer growth via reactive oxygen species-dependent apoptosis and autophagy. J Cell Mol Med. 2018 Aug;22(8):3795-3807. doi: 10.1111/jcmm.13647. Epub 2018 Jun 19. PMID: 29923307; PMCID: PMC6050496.
5: Jia L, Zhou J, Zhao H, Jin H, Lv M, Zhao N, Zheng Z, Lu Y, Ming Y, Yu Y. Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail‑glycolysis pathways. Oncol Rep. 2017 Oct;38(4):2464-2470. doi: 10.3892/or.2017.5886. Epub 2017 Aug 7. PMID: 28791374.
6: Attar R, Cincin ZB, Bireller ES, Cakmakoglu B. Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line. Onco Targets Ther. 2017 Mar 31;10:1941-1946. doi: 10.2147/OTT.S135315. PMID: 28408846; PMCID: PMC5384738.
7: Li X, Deng Y, Zheng Z, Huang W, Chen L, Tong Q, Ming Y. Corilagin, a promising medicinal herbal agent. Biomed Pharmacother. 2018 Mar;99:43-50. doi: 10.1016/j.biopha.2018.01.030. Epub 2018 Jan 8. PMID: 29324311.
8: Jia L, Jin H, Zhou J, Chen L, Lu Y, Ming Y, Yu Y. A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways. BMC Complement Altern Med. 2013 Feb 15;13:33. doi: 10.1186/1472-6882-13-33. PMID: 23410205; PMCID: PMC3598193.
9: Liu J, Qin X, Ma W, Jia S, Zhang X, Yang X, Pan D, Jin F. Corilagin induces apoptosis and autophagy in NRF2‑addicted U251 glioma cell line. Mol Med Rep. 2021 May;23(5):320. doi: 10.3892/mmr.2021.11959. Epub 2021 Mar 24. PMID: 33760110; PMCID: PMC7974271.
10: Gu Y, Xiao L, Ming Y, Zheng Z, Li W. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo. Int J Oncol. 2016 May;48(5):1868-76. doi: 10.3892/ijo.2016.3413. Epub 2016 Mar 2. PMID: 26935808; PMCID: PMC4809656.
11: Jin X, Fu Q, Gu Z, Zhang Z, Lv H. Injectable corilagin/low molecular weight chitosan/PLGA-PEG-PLGA thermosensitive hydrogels for localized cancer therapy and promoting drug infiltration by modulation of tumor microenvironment. Int J Pharm. 2020 Nov 15;589:119772. doi: 10.1016/j.ijpharm.2020.119772. Epub 2020 Aug 13. PMID: 32800934.
12: Deng Y, Li X, Li X, Zheng Z, Huang W, Chen L, Tong Q, Ming Y. Corilagin induces the apoptosis of hepatocellular carcinoma cells through the mitochondrial apoptotic and death receptor pathways. Oncol Rep. 2018 Jun;39(6):2545-2552. doi: 10.3892/or.2018.6396. Epub 2018 Apr 23. PMID: 29693193; PMCID: PMC5983927.
13: Qin X, Liu J, Pan D, Ma W, Cheng P, Jin F. Corilagin induces human glioblastoma U251 cell apoptosis by impeding activity of (immuno)proteasome. Oncol Rep. 2021 Apr;45(4):34. doi: 10.3892/or.2021.7985. Epub 2021 Mar 2. PMID: 33649855; PMCID: PMC7905533.
14: Qiu F, Liu L, Lin Y, Yang Z, Qiu F. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8. Anticancer Agents Med Chem. 2019;19(8):1021-1028. doi: 10.2174/1871520619666190307120811. PMID: 30848215.
15: Tong F, Zhang J, Liu L, Gao X, Cai Q, Wei C, Dong J, Hu Y, Wu G, Dong X. Corilagin Attenuates Radiation-Induced Brain Injury in Mice. Mol Neurobiol. 2016 Dec;53(10):6982-6996. doi: 10.1007/s12035-015-9591-6. Epub 2015 Dec 15. PMID: 26666668.
16: Lv B, Li X, Wang H. Corilagin decreases insulin resistance in polycystic ovary syndrome rat model through regulating AMPK/GSK3β pathway. Transl Cancer Res. 2020 May;9(5):3242-3248. doi: 10.21037/tcr.2020.04.27. PMID: 35117690; PMCID: PMC8798515.
17: Jia S, He D, Liang X, Cheng P, Liu J, Chen M, Wang C, Zhang H, Meng C. Corilagin induces apoptosis and inhibits autophagy of HL‑60 cells by regulating miR‑451/HMGB1 axis. Mol Med Rep. 2022 Jan;25(1):34. doi: 10.3892/mmr.2021.12550. Epub 2021 Dec 1. PMID: 34850958; PMCID: PMC8669704.
18: Zhang L, Jia B, Velu P, Wu H. Corilagin induces apoptosis and inhibits HMBG1/PI3K/AKT signaling pathways in a rat model of gastric carcinogenesis induced by methylnitronitrosoguanidine. Environ Toxicol. 2022 May;37(5):1222-1230. doi: 10.1002/tox.23478. Epub 2022 Feb 1. PMID: 35103375.
19: Yu X, Wu T, Liao B, Du Z, Zhu P. Anticancer potential of corilagin on T24 and TSGH 8301 bladder cancer cells via the activation of apoptosis by the suppression of NF-κB-induced P13K/Akt signaling pathway. Environ Toxicol. 2022 May;37(5):1152-1159. doi: 10.1002/tox.23472. Epub 2022 Jan 27. PMID: 35084093.
20: Yang MH, Baek SH, Hwang ST, Um JY, Ahn KS. Corilagin exhibits differential anticancer effects through the modulation of STAT3/5 and MAPKs in human gastric cancer cells. Phytother Res. 2022 Jun;36(6):2449-2462. doi: 10.1002/ptr.7419. Epub 2022 Mar 2. PMID: 35234310.